Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
Adrià Cañellas‐Socias, Carme Cortina, Xavier Hernando‐Momblona, Sergio Palomo‐Ponce, Eoghan J. Mulholland, Gemma Turón, Lídia Mateo, Sefora Conti, Olga Roman, Marta Sevillano, Felipe Slebe, Diana Stork, Adrià Caballé, Antonio Berenguer, Adrián Álvarez-Varela, Nicola Fenderico, Laura Novellasdemunt, Laura Jiménez-Gracia, Tamara Sipka, Lídia Bardia, Patricia Lorden, Julien Colombelli, Holger Heyn, Xavier Trepat, Sabine Tejpar, Elena Sancho, Daniele V. F. Tauriello, Simon J. Leedham, Camille Stephan‐Otto Attolini, Eduard Batlle
Topics & Concepts
MedicineColorectal cancerPopulationCancer researchOncologyLGR5DiseaseMinimal residual diseaseInternal medicinePrimary tumorCancerPathologyMetastasisEnvironmental healthLeukemiaCancer Cells and MetastasisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis